These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 32379722)

  • 1. Purpureocillium lilacinum as unusual cause of pulmonary infection in immunocompromised hosts.
    Salazar-González MA; Violante-Cumpa JR; Alfaro-Rivera CG; Villanueva-Lozano H; Treviño-Rangel RJ; González GM
    J Infect Dev Ctries; 2020 Apr; 14(4):415-419. PubMed ID: 32379722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic studies on Purpureocillium lilacinum reveal molecular mechanisms of response to fluconazole and itraconazole.
    Pedezzi R; de Biagi Junior CAO; de Freitas MCC; da Rosa-Garzon NG; Cabral H
    Braz J Microbiol; 2021 Jun; 52(2):491-501. PubMed ID: 33651333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purpureocillium lilacinum tattoo-related skin infection in a kidney transplant recipient.
    Trinh SA; Angarone MP
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe pneumonia with pleural effusion caused by co-infection of Paecilomyces variotii and Penicillium oxalicum in a diabetic patient.
    Wang X; Chen X; Liang Y; Hu L
    BMC Infect Dis; 2024 Jun; 24(1):605. PubMed ID: 38898444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isavuconazonium for the treatment of Purpureocillium lilacinum infection in a patient with pyoderma gangrenosum.
    Accetta J; Powell E; Boh E; Bull L; Kadi A; Luk A
    Med Mycol Case Rep; 2020 Sep; 29():18-21. PubMed ID: 32547913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purpureocillium lilacinum-related endophthalmitis: case report.
    Ros-Sánchez E; Oliver-Gutierrez D; Buck P; Goncharova T; Distefano L; Kirkegaard-Biosca E
    J Ophthalmic Inflamm Infect; 2024 Jun; 14(1):27. PubMed ID: 38867117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Hyalohyphomycosis and Its Atypical Clinical Presentations in Immunosuppressed Patients.
    Ferara N; Špoljar S; Lugović-Mihić L; Gverić Grginić A; Rezo Vranješ V; Bešlić I; Perović J; Regović Džombeta T
    Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38276283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe influenza A virus pneumonia complicated with
    Zhang Y; Li H; Chen L; Feng F; Liu L; Guo Q
    Front Cell Infect Microbiol; 2023; 13():1289235. PubMed ID: 38162579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous fungal infection in an immunocompromised host.
    Sotello D; Cappel M; Huff T; Meza D; Alvarez S; Libertin CR
    JMM Case Rep; 2017 Jun; 4(6):e005101. PubMed ID: 29026628
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary endemic mycoses.
    Wilson MJ; Harding I; Borman AM; Johnson E; Miller R
    Clin Med (Lond); 2024 Jan; 24(1):100014. PubMed ID: 38382182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Diagnostic Approach to Fungal Pneumonia: An Infectious Diseases Perspective.
    Azar MM
    Chest; 2024 Mar; 165(3):559-572. PubMed ID: 37813181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Pulmonary Infections in Clinical Practice.
    Febbo JA; Ketai L
    Adv Clin Radiol; 2021 Sep; 3():103-124. PubMed ID: 38620910
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of
    Yang XL; Zhang JY; Ren JM
    World J Clin Cases; 2024 Apr; 12(10):1772-1777. PubMed ID: 38660073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complicated multiple organ infection of
    Hu X; Zhang L; Lin Q; Zhang F; Zhao X
    Blood Sci; 2022 Apr; 4(2):89-92. PubMed ID: 35957666
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic and therapeutic challenges of treating opportunistic fungal cellulitis: a case series.
    Paul J; Czech MM; Balijepally R; Brown JW
    BMC Infect Dis; 2022 May; 22(1):435. PubMed ID: 35513796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.
    Cao D; Liu W; Lyu N; Li B; Song W; Yang Y; Zhu J; Zhang Z; Zhu B
    Microbiol Spectr; 2021 Dec; 9(3):e0061521. PubMed ID: 34908436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature.
    Sprute R; Salmanton-García J; Sal E; Malaj X; Ráčil Z; Ruiz de Alegría Puig C; Falces-Romero I; Barać A; Desoubeaux G; Kindo AJ; Morris AJ; Pelletier R; Steinmann J; Thompson GR; Cornely OA; Seidel D; Stemler J;
    J Antimicrob Chemother; 2021 May; 76(6):1593-1603. PubMed ID: 33599275
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.